Peabody John J, Hadley Steven M, Bergman Rachel, Westvold Sarah J, Olamigoke Fikayo O, Chang Shaun, Patel Milap, Kadakia Anish R
Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Department of Orthopaedic Surgery, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
J Orthop Surg Res. 2025 Apr 18;20(1):390. doi: 10.1186/s13018-025-05748-6.
Prior studies have compared patient-reported outcomes between open repair and one of either the two minimally invasive techniques for Achilles tendon rupture: Percutaneous Achilles Repair System (PARS) and Midsubstance Speedbridge Implant System (MSB). However, no study has compared patient-reported outcomes measured by Patient Reported Outcomes Measurement Information System (PROMIS) physical function (PF) and PROMIS pain interference (PI) and the Achilles Tendon Total Rupture Score (ATRS) between PARS and MSB. Our study compared patient-reported outcomes measured by PROMIS and ATRS scores between PARS and MSB. We hypothesized that patient-reported outcomes would be similar between groups.
This was a retrospective review of 434 patients who underwent Achilles rupture repair from 2018 to 2023 at a single institution. Tendinopathies, open injuries, concomitant fractures, tendon transfers, gastrocnemius recessions, and open repairs were excluded. A total of 316 patients met inclusion criteria and were contacted to complete a postoperative questionnaire containing PROMIS and ATRS. 119 (78 PARS and 41 MSB) completed all surveys and were included for final analysis. Wilcoxon rank-sum and Kruskal-Wallis tests were used to assess differences in mean scores. Chi-squared and Fisher's exact tests were used to compare incidence of complications. All tests were conducted at a significance level of α = 0.05.
Average follow-up was 30 months at time of survey completion. There were no significant differences in PROMIS PF, PROMIS PI, and ATRS measures between groups (p > 0.05). Mean PARS PROMIS PF, PROMIS PI, and ATRS were 58.8, 44.2, and 86.0, respectively. Mean MSB PROMIS PF, PROMIS PI, and ATRS were 55.3, 44.0, and 82.5, respectively. No significant differences existed in incidence of each postoperative complication between groups (p > 0.05).
In the largest study to compare patient-reported outcomes between PARS and MSB, outcomes were similar between both groups. Both techniques resulted in PROMIS PF greater than the population mean and PROMIS PI lower than the population mean. Each had similar ATRS scores. Overall, both MSB and PARS were safe and effective strategies for surgically managing Achilles ruptures.
先前的研究比较了开放性修复与两种微创技术之一(经皮跟腱修复系统(PARS)和中间段速桥植入系统(MSB))治疗跟腱断裂患者报告的结局。然而,尚无研究比较PARS和MSB之间通过患者报告结局测量信息系统(PROMIS)身体功能(PF)、PROMIS疼痛干扰(PI)和跟腱完全断裂评分(ATRS)所测得的患者报告结局。我们的研究比较了PARS和MSB之间通过PROMIS和ATRS评分所测得的患者报告结局。我们假设两组之间患者报告的结局相似。
这是一项对2018年至2023年在单一机构接受跟腱断裂修复的434例患者的回顾性研究。排除肌腱病、开放性损伤、合并骨折、肌腱转移、腓肠肌退缩和开放性修复。共有316例患者符合纳入标准,并被联系以完成一份包含PROMIS和ATRS的术后问卷。119例(78例PARS和41例MSB)完成了所有调查并纳入最终分析。采用Wilcoxon秩和检验和Kruskal-Wallis检验评估平均得分差异。采用卡方检验和Fisher精确检验比较并发症发生率。所有检验均在显著性水平α = 0.05下进行。
在完成调查时,平均随访时间为30个月。两组之间在PROMIS PF、PROMIS PI和ATRS测量方面无显著差异(p > 0.05)。PARS组的平均PROMIS PF、PROMIS PI和ATRS分别为58.8、44.2和86.0。MSB组的平均PROMIS PF、PROMIS PI和ATRS分别为55.3、44.0和82.5。两组之间各术后并发症的发生率无显著差异(p > 0.05)。
在比较PARS和MSB之间患者报告结局的最大规模研究中,两组的结局相似。两种技术均使PROMIS PF高于总体均值,PROMIS PI低于总体均值。两者的ATRS评分相似。总体而言,MSB和PARS都是手术治疗跟腱断裂的安全有效策略。